angiotensin ii has been researched along with Atrophy, Muscle in 34 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 9 (26.47) | 29.6817 |
2010's | 20 (58.82) | 24.3611 |
2020's | 5 (14.71) | 2.80 |
Authors | Studies |
---|---|
Hoshino, S; Ichikawa, D; Inoue, K; Kamijo-Ikemori, A; Kimura, K; Kotake, H; Ogura, Y; Ohata, K; Shibagaki, Y; Sugaya, T; Takayama, S; Watanabe, M | 1 |
Bi, X; Ding, W; Liu, Y; Wang, Y; Zhang, Y | 1 |
Chen, R; Das, S; Hua, X; Li, J; Tang, H; Wang, L; Xiao, J; Yang, T | 1 |
Anzai, T; Fukushima, A; Kakutani, N; Kinugawa, S; Kitaura, Y; Nakano, I; Obata, Y; Shimomura, Y; Takada, S; Yamanashi, K; Yokota, T | 1 |
Cao, C; Hasegawa, Y; Kim-Mitsuyama, S; Koibuchi, N; Lin, B; Takane, K; Yokoo, T | 1 |
Bao, R; Gupta, MP; Kanwal, A; Pillai, VB; Samant, SA | 1 |
Fukushima, A; Furihata, T; Kadoguchi, T; Kinugawa, S; Matsumoto, J; Mizushima, W; Okita, K; Takada, S; Tsuda, M; Yokota, T | 1 |
Hall, SE; Winslow, MA | 1 |
Gao, J; Shen, W; Sun, M; Wu, X; Zhang, Q; Zheng, J | 1 |
Delafontaine, P; Galvez, S; Higashi, Y; Mitch, WE; Sukhanov, S; Tabony, AM; Yoshida, T | 1 |
Cavasin, MA; Chen, B; Demos-Davies, KM; Ferguson, BS; Ferrara, C; Horn, TR; Jeong, MY; Mahaffey, JH; McKinsey, TA; Piroddi, N; Poggesi, C; Scellini, B; Schuetze, KB; Spiltoir, JI; Tesi, C; Williams, SM | 1 |
Abrigo, J; Cabello-Verrugio, C; Cisternas, F; Meneses, C; Morales, MG; Simon, F | 1 |
Abrigo, J; Brandan, E; Cabello-Verrugio, C; Cisternas, F; Meneses, C; Morales, MG; Simon, F; Vazquez, Y | 1 |
Abrigo, J; Brandan, E; Cabello-Verrugio, C; Meneses, C; Morales, MG; Simon, F | 1 |
Fukushima, A; Furihata, T; Homma, T; Kadoguchi, T; Kinugawa, S; Masaki, Y; Matsushima, S; Mizushima, W; Nishikawa, M; Okita, K; Takada, S; Takahashi, M; Tsutsui, H; Yokota, T | 1 |
Delafontaine, P; Yoshida, T | 2 |
Bassel-Duby, R; Du Bois, P; Fielitz, J; Kny, M; Lodka, D; Olson, EN; Pablo Tortola, C; Schmidt, F; Schmidt, S; Song, K | 1 |
Bao, M; Li, Y; Liang, C; Liu, B; Pan, X; Shen, C; Song, JL; Song, YH; Wang, J; Wang, X; Wu, C; Yu, XY; Zhao, Q; Zhou, J | 1 |
Borst, SE; Giovannini, S; Leeuwenburgh, C; Marzetti, E | 1 |
Eley, HL; Russell, ST; Tisdale, MJ | 2 |
Delafontaine, P; Du, J; Garcia, G; Han, G; Hu, Z; Mitch, WE; Zhang, L | 1 |
Delafontaine, P; Gonzalez-Villalobos, RA; Michael Tabony, A; Rezk, BM; Semprun-Prieto, LC; Sukhanov, S; Vaughn, C; Yoshida, T | 1 |
Delafontaine, P; Galvez, S; Higashi, Y; Michael Tabony, A; Semprun-Prieto, L; Sukhanov, S; Yoshida, T | 1 |
Chandrasekar, B; Delafontaine, P; Galvez, S; Higashi, Y; Mitch, WE; Sukhanov, S; Tabony, AM; Yoshida, T | 1 |
Delafontaine, P; Higashi, Y; Rezk, BM; Semprun-Prieto, L; Sukhanov, S; Yoshida, T | 1 |
Cabello-Verrugio, C; Córdova, G; Salas, JD | 1 |
Su, Q; Zhou, Y | 1 |
Angelini, A; Dalla Libera, L; Danieli Betto, D; Della Barbera, M; Germinario, E; Gobbo, V; Ravara, B; Vescovo, G; Volterrani, M | 1 |
Arneja, AS; Dhalla, NS; Ganguly, PK; Netticadan, T; Shah, KR | 1 |
Akao, M; Delafontaine, P | 1 |
Eley, HL; Tisdale, MJ | 1 |
Angelini, A; Battista Ambrosio, G; Dalla Libera, L; Ravara, B; Rossini, K; Sandri, M; Thiene, G; Vescovo, G | 1 |
6 review(s) available for angiotensin ii and Atrophy, Muscle
Article | Year |
---|---|
Muscle wasting: A review of exercise, classical and non-classical RAS axes.
Topics: Angiotensin I; Angiotensin II; Apoptosis; Exercise; Fibrosis; Humans; Mitochondria; Muscle, Skeletal; Muscular Atrophy; NADPH Oxidases; Peptide Fragments; Protein Biosynthesis; Reactive Oxygen Species; Renin-Angiotensin System; Ubiquitin-Protein Ligases | 2019 |
Molecular mechanisms and signaling pathways of angiotensin II-induced muscle wasting: potential therapeutic targets for cardiac cachexia.
Topics: Angiotensin II; Animals; Cachexia; Heart Diseases; Humans; Molecular Targeted Therapy; Muscle, Skeletal; Muscular Atrophy; Signal Transduction | 2013 |
Modulation of GH/IGF-1 axis: potential strategies to counteract sarcopenia in older adults.
Topics: Aged; Aging; Angiotensin II; Body Weight; Growth Hormone; Humans; Hypothalamus; Insulin-Like Growth Factor I; Models, Biological; Muscle, Skeletal; Muscles; Muscular Atrophy | 2008 |
Angiotensin II, oxidative stress and skeletal muscle wasting.
Topics: Angiotensin II; Animals; Humans; Mice; Mitochondria, Muscle; Muscular Atrophy; NADPH Oxidases; Oxidative Stress; Reactive Oxygen Species; Receptors, Angiotensin | 2011 |
Angiotensin II: role in skeletal muscle atrophy.
Topics: Angiotensin II; Animals; Humans; Muscle, Skeletal; Muscular Atrophy; Receptors, Angiotensin; Renin-Angiotensin System; Signal Transduction | 2012 |
Angiotensin II as candidate of cardiac cachexia.
Topics: Angiotensin II; Cachexia; Heart Failure; Humans; Insulin-Like Growth Factor I; Muscle, Skeletal; Muscular Atrophy | 2006 |
28 other study(ies) available for angiotensin ii and Atrophy, Muscle
Article | Year |
---|---|
Angiotensin II type 1a receptor deficiency alleviates muscle atrophy after denervation.
Topics: Angiotensin II; Animals; Denervation; Male; Mice; Mice, Knockout; Muscle, Skeletal; Muscular Atrophy; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Ubiquitin-Protein Ligases | 2023 |
Mitochondrial dysfunction/NLRP3 inflammasome axis contributes to angiotensin II-induced skeletal muscle wasting via PPAR-γ.
Topics: Angiotensin II; Animals; Cell Line; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitochondria; Muscle, Skeletal; Muscular Atrophy; NLR Family, Pyrin Domain-Containing 3 Protein; PPAR gamma | 2020 |
CRISPR/Cas9-Mediated miR-29b Editing as a Treatment of Different Types of Muscle Atrophy in Mice.
Topics: Angiotensin II; Animals; CRISPR-Associated Protein 9; CRISPR-Cas Systems; Dependovirus; Disease Models, Animal; Gene Editing; Genetic Therapy; HEK293 Cells; Humans; Immobilization; Injections, Intramuscular; Male; Mice; Mice, Inbred C57BL; MicroRNAs; Muscle Denervation; Muscular Atrophy; Myoblasts, Skeletal; RNA, Guide, Kinetoplastida; RNA, Messenger; Signal Transduction; Treatment Outcome | 2020 |
Branched-chain amino acid supplementation ameliorates angiotensin II-induced skeletal muscle atrophy.
Topics: Amino Acids, Branched-Chain; Angiotensin II; Animals; Blood Pressure; Echocardiography; Male; Mice; Mice, Inbred C57BL; Muscle Fibers, Skeletal; Muscle, Skeletal; Muscular Atrophy; Phosphorylation; Physical Conditioning, Animal; Renin-Angiotensin System; Signal Transduction | 2020 |
Detrimental Effects of Centrally Administered Angiotensin II are Enhanced in a Mouse Model of Alzheimer Disease Independently of Blood Pressure.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Angiotensin II; Animals; Behavior, Animal; Blood Pressure; Brain; Cognition; Disease Models, Animal; Hippocampus; Inflammation; Infusions, Intraventricular; Male; Mice; Mice, Transgenic; Muscle, Skeletal; Muscular Atrophy; Oxidative Stress; Sarcopenia; Vasoconstrictor Agents | 2017 |
The histone deacetylase SIRT6 blocks myostatin expression and development of muscle atrophy.
Topics: Activin Receptors, Type II; Activins; Angiotensin II; Animals; Humans; Mice; Mice, Knockout; Muscle, Skeletal; Muscular Atrophy; Myocardium; Myostatin; NF-kappa B; Rats; Response Elements; Sirtuins; Up-Regulation | 2017 |
Deletion of NAD(P)H Oxidase 2 Prevents Angiotensin II-Induced Skeletal Muscle Atrophy.
Topics: Angiotensin II; Animals; Gene Expression; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle Proteins; Muscle, Skeletal; Muscular Atrophy; NADPH Oxidase 2; Phosphorylation; Proto-Oncogene Proteins c-akt; SKP Cullin F-Box Protein Ligases | 2018 |
Sirtuin 3 deficiency accelerates Angiotensin II-induced skeletal muscle atrophy.
Topics: Angiotensin II; Animals; Male; Mice, Inbred C57BL; Mice, Knockout; Mitochondria, Muscle; Muscle Fibers, Skeletal; Muscle, Skeletal; Muscular Atrophy; Sirtuin 3 | 2020 |
HDAC6 contributes to pathological responses of heart and skeletal muscle to chronic angiotensin-II signaling.
Topics: Angiotensin II; Animals; Cardiomegaly; Disease Models, Animal; Fibrosis; Heart Failure; Histone Deacetylase 6; Histone Deacetylase Inhibitors; Histone Deacetylases; Hydroxamic Acids; Indoles; Male; Mice; Mice, Knockout; Muscle, Skeletal; Muscular Atrophy; Myocardium; Signal Transduction; Stroke Volume; Systole; Time Factors; Ventricular Function, Left; Ventricular Remodeling | 2014 |
Expression of the Mas receptor is upregulated in skeletal muscle wasting.
Topics: Angiotensin II; Animals; Cells, Cultured; Immunoblotting; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Muscle, Skeletal; Muscular Atrophy; Polymerase Chain Reaction; Protein Binding; Receptors, G-Protein-Coupled; Up-Regulation | 2015 |
Angiotensin-(1-7) decreases skeletal muscle atrophy induced by angiotensin II through a Mas receptor-dependent mechanism.
Topics: Angiotensin I; Angiotensin II; Animals; Cell Line; Gene Expression Regulation; Male; Mice, Inbred C57BL; Muscle Fibers, Skeletal; Muscle Proteins; Muscle Strength; Muscle, Skeletal; Muscular Atrophy; Myosin Heavy Chains; Peptide Fragments; Phosphorylation; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Receptors, G-Protein-Coupled; Signal Transduction; SKP Cullin F-Box Protein Ligases; Tripartite Motif Proteins; Ubiquitin-Protein Ligases | 2015 |
The angiotensin-(1-7)/Mas axis reduces myonuclear apoptosis during recovery from angiotensin II-induced skeletal muscle atrophy in mice.
Topics: Angiotensin I; Angiotensin II; Animals; Apoptosis; Disease Models, Animal; Immunoblotting; In Situ Nick-End Labeling; Male; Mice; Mice, Inbred C57BL; Muscle, Skeletal; Muscular Atrophy; Peptide Fragments; Polymerase Chain Reaction; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled | 2015 |
Angiotensin II can directly induce mitochondrial dysfunction, decrease oxidative fibre number and induce atrophy in mouse hindlimb skeletal muscle.
Topics: Angiotensin I; Angiotensin II; Animals; Caspase 3; DNA Nucleotidylexotransferase; Hindlimb; Male; Mice; Mice, Inbred C57BL; Mitochondria; Muscle Fibers, Skeletal; Muscle Proteins; Muscular Atrophy; NADPH Oxidases; Oxidation-Reduction; Renin-Angiotensin System | 2015 |
Mechanisms of Cachexia in Chronic Disease States.
Topics: Angiotensin II; Animals; Cachexia; Cell Proliferation; Chronic Disease; Cytokines; Humans; Muscle Proteins; Muscles; Muscular Atrophy; Oxidative Stress; Proteasome Endopeptidase Complex; Proteins; Regeneration; Renin-Angiotensin System; Signal Transduction; Ubiquitin | 2015 |
Angiotensin II Induces Skeletal Muscle Atrophy by Activating TFEB-Mediated MuRF1 Expression.
Topics: Angiotensin II; Animals; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Gene Expression Regulation; Humans; Mice; Mice, Knockout; Muscle Proteins; Muscular Atrophy; Tripartite Motif Proteins; Ubiquitin-Protein Ligases | 2015 |
THE RENIN-ANGIOTENSIN SYSTEM AND THE BIOLOGY OF SKELETAL MUSCLE: MECHANISMS OF MUSCLE WASTING IN CHRONIC DISEASE STATES.
Topics: Angiotensin II; Animals; Cachexia; Chronic Disease; Humans; Mice; Muscle, Skeletal; Muscular Atrophy; Renin-Angiotensin System; Sarcopenia | 2016 |
Angiotensin-II-induced Muscle Wasting is Mediated by 25-Hydroxycholesterol via GSK3β Signaling Pathway.
Topics: Angiotensin II; Animals; Blotting, Western; Cell Line; Cells, Cultured; Gene Expression Profiling; Glycogen Synthase Kinase 3 beta; Hydroxycholesterols; Insulin-Like Growth Factor I; Male; Mice, Inbred C57BL; Mice, Knockout; Muscle Proteins; Muscle, Skeletal; Muscular Atrophy; Myoblasts; Proto-Oncogene Proteins c-akt; Receptors, Tumor Necrosis Factor, Type I; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; SKP Cullin F-Box Protein Ligases; Steroid Hydroxylases; Thiadiazoles; Tumor Necrosis Factor-alpha | 2017 |
Mechanism of attenuation of muscle protein degradation induced by tumor necrosis factor-alpha and angiotensin II by beta-hydroxy-beta-methylbutyrate.
Topics: Angiotensin II; Animals; Caspase 3; Caspase 8; Cells, Cultured; Down-Regulation; Drug Evaluation, Preclinical; Enzyme Inhibitors; Imidazoles; Interferon-gamma; Metabolic Networks and Pathways; Mice; Models, Biological; Muscle Fibers, Skeletal; Muscle Proteins; Muscular Atrophy; p38 Mitogen-Activated Protein Kinases; Phenylalanine; Protein Processing, Post-Translational; Pyridines; Reactive Oxygen Species; Tumor Necrosis Factor-alpha; Valerates | 2008 |
Attenuation of depression of muscle protein synthesis induced by lipopolysaccharide, tumor necrosis factor, and angiotensin II by beta-hydroxy-beta-methylbutyrate.
Topics: Adaptor Proteins, Signal Transducing; Angiotensin II; Animals; Carrier Proteins; Cell Cycle Proteins; Cells, Cultured; Down-Regulation; Drug Evaluation, Preclinical; eIF-2 Kinase; Eukaryotic Initiation Factor-4E; Eukaryotic Initiation Factor-4G; Eukaryotic Initiation Factors; Lipopolysaccharides; Mice; Muscle Fibers, Skeletal; Muscle Proteins; Muscular Atrophy; Phosphoproteins; Phosphorylation; Protein Biosynthesis; Tumor Necrosis Factors; Valerates | 2008 |
IL-6 and serum amyloid A synergy mediates angiotensin II-induced muscle wasting.
Topics: Angiotensin II; Animals; Cell Line; Humans; Insulin Receptor Substrate Proteins; Interleukin-6; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle Fibers, Skeletal; Muscular Atrophy; Proto-Oncogene Proteins c-akt; Rats; Receptors, Angiotensin; Recombinant Proteins; Renal Insufficiency, Chronic; Serum Amyloid A Protein; Suppressor of Cytokine Signaling Proteins; Wasting Syndrome | 2009 |
Angiotensin II induced catabolic effect and muscle atrophy are redox dependent.
Topics: Angiotensin II; Animals; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Muscle, Skeletal; Muscular Atrophy; NADPH Oxidases; Oxidation-Reduction; Proteasome Endopeptidase Complex; Reactive Oxygen Species; Superoxides; Wasting Syndrome | 2011 |
Angiotensin II upregulates protein phosphatase 2Cα and inhibits AMP-activated protein kinase signaling and energy balance leading to skeletal muscle wasting.
Topics: Adenosine Triphosphate; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Angiotensin II; Animals; Energy Metabolism; Male; Mice; Mice, Inbred Strains; Mitochondria, Muscle; Models, Animal; Muscle, Skeletal; Muscular Atrophy; Phosphoprotein Phosphatases; Protein Phosphatase 2C; Ribonucleotides; Signal Transduction; Ubiquitin-Protein Ligases; Up-Regulation | 2011 |
Angiotensin II infusion induces marked diaphragmatic skeletal muscle atrophy.
Topics: Angiotensin II; Animals; bcl-2-Associated X Protein; Diaphragm; Flow Cytometry; Immunoblotting; Male; Mice; Muscle Proteins; Muscle, Skeletal; Muscular Atrophy; Real-Time Polymerase Chain Reaction; Regeneration; Tripartite Motif Proteins; Ubiquitin-Protein Ligases | 2012 |
[Effects of angiotensin II on the type of the skeletal muscle of amyotrophic rat].
Topics: Angiotensin II; Animals; Male; Muscle, Skeletal; Muscular Atrophy; Rats; Rats, Sprague-Dawley | 2012 |
Beneficial effects of GH/IGF-1 on skeletal muscle atrophy and function in experimental heart failure.
Topics: Angiotensin II; Animals; Apoptosis; Body Weight; Cardiac Output, Low; Caspases; Cytochromes c; Human Growth Hormone; In Situ Nick-End Labeling; Insulin-Like Growth Factor I; Isometric Contraction; Male; Monocrotaline; Muscle, Skeletal; Muscular Atrophy; Myosin Heavy Chains; Physical Endurance; Rats; Rats, Sprague-Dawley; Sphingosine; Tumor Necrosis Factor-alpha | 2004 |
Changes in skeletal muscle SR Ca2+ pump in congestive heart failure due to myocardial infarction are prevented by angiotensin II blockade.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Apoptosis; Calcium; Calcium-Transporting ATPases; Captopril; Cyclic AMP-Dependent Protein Kinases; Enalapril; Heart Failure; Imidazolidines; Losartan; Male; Muscle, Skeletal; Muscular Atrophy; Myocardial Infarction; Rats; Rats, Sprague-Dawley; Sarcoplasmic Reticulum; Time Factors | 2004 |
Skeletal muscle atrophy, a link between depression of protein synthesis and increase in degradation.
Topics: Angiotensin II; Animals; Cells, Cultured; eIF-2 Kinase; Eukaryotic Initiation Factor-2; Mice; Muscle Proteins; Muscle, Skeletal; Muscular Atrophy; NF-kappa B; Phosphorylation; Protein Biosynthesis; Proteoglycans | 2007 |
Beneficial effects on skeletal muscle of the angiotensin II type 1 receptor blocker irbesartan in experimental heart failure.
Topics: Angiotensin II; Animals; Apoptosis; Biphenyl Compounds; Calcium Channel Blockers; Drug Evaluation, Preclinical; Gene Expression Regulation; Heart Failure; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Infusion Pumps, Implantable; Irbesartan; Male; Monocrotaline; Muscle Fibers, Fast-Twitch; Muscle Fibers, Slow-Twitch; Muscle Proteins; Muscle, Skeletal; Muscular Atrophy; Nifedipine; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Tetrazoles; Tumor Necrosis Factor-alpha | 2001 |